OMKAR KUMAR KUWAR

About

A dedicated researcher and academician in the field of pharmaceutical sciences, with a strong focus on neuropharmacology and molecular mechanisms underlying neurodegenerative disorders such as Huntington’s and Parkinson’s disease. My research interests lie in exploring the therapeutic potential of natural compounds and synthetic agents through in vivo and in vitro models, with emphasis on signaling pathways like Nrf2/KEAP1 and NF-κB. I am also involved in pharmacological evaluations, biochemical analyses, and histopathological investigations to understand disease pathology and intervention outcomes. Passionate about teaching, I aim to integrate evidence-based research into pharmacy education and contribute to advancements in drug discovery and development.

Employment

• Bihar College of Pharmacy Assistant Professor
  2025 - Present

Education

• Indo Soviet Friendship College of Pharmacy M.pharm
  2023 - 2025
• Mewar University B.pharm
  2019 - 2023

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• The interplay between inflammation and oxidative stress in depression: pathogenic mechanisms and treatment approaches
  Molecular Biology Reports 2026 DOI: 10.1007/s11033-025-11393-3
  +Save
• Therapeutic potential of sulforaphane in neurodegenerative diseases: mechanistic Insights into Nrf2, NF-κB, TrkB, SIRT1, MAPK, and JAK/STAT signalling pathways
  Molecular Biology Reports 2026 DOI: 10.1007/s11033-026-11729-7
  +Save
• The gut-brain-mitochondria axis in type 2 diabetes-associated cognitive decline: mechanistic convergence, biomarkers, and therapeutic opportunities
  Acta Diabetologica 2026 DOI: 10.1007/s00592-026-02749-7
  +Save
• α-Klotho as a central integrative signalling hub in cognitive function and neuroprotection in neurodegenerative diseases
  Metabolic Brain Disease 2026 DOI: 10.1007/s11011-026-01897-7
  +Save
• Methamphetamine-Driven Neuroinflammation and Parkinson’s Disease Pathology: Mechanistic Insight into Nrf2 and NFĸB Signaling
  Molecular Neurobiology 2026 DOI: 10.1007/s12035-026-05674-6
  +Save
• Mitochondrial Dysfunction as a Driver of Neurodegeneration in Parkinson’s and Huntington’s Disease: Molecular Insights and Emerging Interventions
  Molecular Neurobiology 2026 DOI: 10.1007/s12035-026-05991-w
  +Save
• The KEAP1-Cullin3-RBX1-Nrf2 Axis in Redox Homeostasis: Molecular Mechanisms, Pathophysiological Roles, and Precision Therapeutic Opportunities
  Molecular Neurobiology 2026 DOI: 10.1007/s12035-025-05313-6
  +Save
• Therapeutic potential of Boswellia serrata in arthritis management: mechanistic insights into COX-2, 5-LOX, and NFĸB modulation
  Inflammopharmacology 2025 DOI: 10.1007/s10787-025-01912-w
  +Save
• Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis
  Inflammopharmacology 2025 DOI: 10.1007/s10787-025-01846-3
  +Save
• Zebrafish Models for Experimental Pharmacology: A Handbook
  Zebrafish Models for Experimental Pharmacology: A Handbook 2025 DOI: 10.2174/97898153246311250101
  +Save